These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19013723

  • 1. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas.
    Schwer AL, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1352-7. PubMed ID: 19013723
    [Abstract] [Full Text] [Related]

  • 2. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):993-1001. PubMed ID: 17967517
    [Abstract] [Full Text] [Related]

  • 3. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
    Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE, Peters KB, Allen K, Hoang JK, Chang Z, Craciunescu O, Vredenburgh JJ, Friedman HS, Kirkpatrick JP.
    Int J Radiat Oncol Biol Phys; 2013 Aug 01; 86(5):873-9. PubMed ID: 23725997
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):303-9. PubMed ID: 22079723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
    Kong DS, Lee JI, Park K, Kim JH, Lim DH, Nam DH.
    Cancer; 2008 May 01; 112(9):2046-51. PubMed ID: 18338759
    [Abstract] [Full Text] [Related]

  • 9. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study.
    Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young B.
    J Neurosurg; 2000 Dec 01; 93 Suppl 3():37-41. PubMed ID: 11143260
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):374-9. PubMed ID: 15667955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery.
    Jarvis LA, Simmons NE, Bellerive M, Erkmen K, Eskey CJ, Gladstone DJ, Hug EB, Roberts DW, Hartford AC.
    Int J Radiat Oncol Biol Phys; 2012 Nov 15; 84(4):943-8. PubMed ID: 22494581
    [Abstract] [Full Text] [Related]

  • 16. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
    Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):51-7. PubMed ID: 21035955
    [Abstract] [Full Text] [Related]

  • 17. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    McDonald MW, Shu HK, Curran WJ, Crocker IR.
    Int J Radiat Oncol Biol Phys; 2011 Jan 01; 79(1):130-6. PubMed ID: 20399036
    [Abstract] [Full Text] [Related]

  • 18. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J, Neil E, Terziev R, Gutin P, Barani I, Kaley T, Lassman AB, Chan TA, Yamada J, DeAngelis L, Ballangrud A, Young R, Panageas KS, Beal K, Omuro A.
    Int J Radiat Oncol Biol Phys; 2017 Nov 15; 99(4):797-804. PubMed ID: 28870792
    [Abstract] [Full Text] [Related]

  • 19. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Franceschi E, Cavallo G, Lonardi S, Magrini E, Tosoni A, Grosso D, Scopece L, Blatt V, Urbini B, Pession A, Tallini G, Crinò L, Brandes AA.
    Br J Cancer; 2007 Apr 10; 96(7):1047-51. PubMed ID: 17353924
    [Abstract] [Full Text] [Related]

  • 20. Extended field stereotactic radiosurgery for recurrent glioblastoma.
    Koga T, Maruyama K, Tanaka M, Ino Y, Saito N, Nakagawa K, Shibahara J, Todo T.
    Cancer; 2012 Sep 01; 118(17):4193-200. PubMed ID: 22180028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.